Fabry disease is a genetic disease which causes deficiency of an enzyme called alpha-galactosidase
A, which is the result of mutations in the GLA gene.
We found statistically significant correlations between increased resistance to 5-fluorocytosine and higher activity of naphthyl phosphohydrolase and lipase; increased resistance to miconazole and higher activity of beta-glucosidase; increased resistance to fluconazole and higher activity of alpha-glucosidase, alpha-galactosidase
, and fucosidase.
He also takes an enzyme blend of amylase, cellulase, lactase, glucoamylase, alpha-galactosidase
Fabry disease is reportedly an inherited lysosomal storage disorder caused by deficiency of an enzyme called alpha-galactosidase
A (alpha-Gal A), which is the result of mutations in the GLA gene.
Low-moisture HPMC capsules and their acid-protection counterparts are excellent for enzymes, including amalyse, protease, lipase, alpha-galactosidase
, bromelain, Enzidase and Isolase.
22) - Pipeline Review, H1 2016', provides in depth analysis on Alpha-Galactosidase
A (Alpha-D-Galactosidase A or Alpha-D-Galactoside Galactohydrolase or Melibiase or EC 3.
Fabry disease (FD) is a disease characterized by the pathological accumulation of glycosphingolipid Gb3 in some cells; it progresses with a lack of lysosomal alpha-galactosidase
and is inherited in an X-linked recessive manner (1).
An orphan disease that has found a solution: enzymatic replacement with alpha-galactosidase
9 It is a rare X-linked recessive disorder, with an incidence of about 1:40 000,10 caused by the mutation in a-galactosidase, a gene on long arm of X chromosome11 and subsequent deficiency of lysosomal hydrolase, alpha-galactosidase
, which results in the progressive deposition of uncleaved neutral glycosphingolipids, predominantly a-galactosyl-lactosyl ceramide (trihexosyl ceramide) within the lysosomes of endothelial, perithelial, smooth muscle cells, autonomic nervous system, kidneys, eyes and heart.
Comparison of chitin and Amberlite IRA-938 for alpha-galactosidase
2009) The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase
A levels in Fabry patient cell lines.
And you can reduce gas production if you take an over-the-counter product, such as Beano or Gas-X Prevention, that contains the enzyme alpha-galactosidase